Command Palette

Search for a command to run...

Clinical Trials · NCT06814938

A Study of a Novel Precision Medicine Approach For Obesity

Active Not RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Active Not Recruiting
Sponsor
Mayo Clinic
Enrollment
135
Start date
Feb 2025
Locations
2 sites, United States
Primary endpoint
Change in Total Body Weight at 24 weeks
View Semaglutide compound reference